Joseph F. Wayland - Sep 19, 2023 Form 4 Insider Report for Chubb Ltd (CB)

Signature
/s/ Samantha Froud, Attorney-in-fact
Stock symbol
CB
Transactions as of
Sep 19, 2023
Transactions value $
-$1,798,425
Form type
4
Date filed
9/21/2023, 08:53 AM
Previous filing
Sep 5, 2023
Next filing
Feb 27, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CB Common Shares Options Exercise $667K +6.89K +7.03% $96.76 105K Sep 19, 2023 Direct
transaction CB Common Shares Sale -$810K -3.79K -3.62% $213.79 101K Sep 19, 2023 Direct F1, F2
transaction CB Common Shares Sale -$1.65M -7.75K -7.66% $213.61 93.3K Sep 19, 2023 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CB Options to Acquire Common Shares Options Exercise $0 -6.89K -6.3% $0.00 103K Sep 19, 2023 Common Shares 6.89K $96.76 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of Common Shares in connection with broker-assisted cashless exercise of options.
F2 The Common Shares reported herein as being sold were sold at a range of between $213.795 and $213.80 per share. The sale price reported above represents the weighted average sale price for the reported transaction and has been rounded to the nearest cent. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such price range.
F3 The sale price reported above has been rounded to the nearest cent.
F4 The stock options vested in equal installments on February 27, 2015, February 27, 2016 and February 27, 2017.
F5 Total includes options from other tranches with different exercise prices, vesting and expiration dates. There are no remaining options from this tranche.

Remarks:

*General Counsel